We covered the outlook for Dr.Reddy’s Laboratories in January. Though the stock hit our stop loss, it has since managed to get past the then mentioned target of Rs.2,850-2,900. We maintain…Continue Reading
The stocks from the pharmaceutical sector have been performing well recently. Be it the large cap ones such as Divis Lab or Lupin or the small and mid cap ones…Continue Reading